Category: Europe
European Coronavirus News
Tocilizumab reduces deaths in patients hospitalised with COVID-19
The Randomised Evaluation of COVID-19 Therapy (RECOVERY) has demonstrated that an anti-inflammatory treatment, tocilizumab, reduces the risk of death when given to hospitalised patients with severe COVID-19. More...
Catalonia schools closed and school groups confined after fresh coronavirus outbreaks
The students confined in Catalonia due to the Covid, after several days of continuous decline, have increased by 279 compared to yesterday and this Thursday they are 34,275 (2.38% of the total). More...
Unexpected detection of SARS-CoV-2 antibodies in Italy in September 2019
Table 1 reports anti-SARS-CoV-2 RBD antibody detection according to the time of sample collection in Italy. More...
Evidence of early circulation of Sars-CoV-2 in France
Using serum samples routinely collected in 9144 adults from a French general population-based cohort, we identified 353 participants with a positive anti-SARS-CoV-2 IgG test, among whom 13 were sampled between November 2019 and January 2020 and were confirmed by neutralizing antibodies testing. More...
Coronavirus had spread across France in November 2019: “One in a thousand was infected”
French researchers have analyzed more than 9,000 blood samples from the months before the pandemic officially broke out and found 13 with traces of SARS-CoV-2. More...
Kent Sars-Cov-2 variant with E484K mutation found in Bristol named VOC 202102/02
A mutated version of the coronavirus variant first detected in Kent has been classified as a cause for “concern” by scientific advisers to the government. More...
14 people test positive for B.1.1.7 coronavirus in Osnabrück despite having 2nd vaccine jab
14 vaccinated retirement home residents tested positive for B.1.1.7 UK coronavirus variant
There has been an outbreak of the British variant of coronavirus in a retirement and nursing home in the Belm district of Osnabrück in Germany. More...
Single Pfizer vaccine shot 90 per cent effective after 21 days
A single dose of the Pfizer vaccine provides “very high” protection from Covid-19 after 21 days – without a ‘top up’ dose in the recommended time frame, according to a new study from the University of East Anglia. More...
Co-infection with 2 distinct SARS-CoV-2 lineages reported in a patient in Portugal
“The patient had co-infection by two SARS-CoV-2 lineages, which were affiliated in distinct clades and diverging by six variants. More...
Lancet report: “interim analysis of the phase 3 trial of Gam-COVID-Vac Sputnik V showed 91·6% efficacy against COVID-19”
“Between Sept 7 and Nov 24, 2020, 21 977 adults were randomly assigned to the vaccine group (n=16 501) or the placebo group (n=5476). More...